Association between body mass index, metabolic syndrome and common urologic conditions: a cross-sectional study using a large multi-institutional database from the United States

Abstract

Introduction The study aims to determine whether body mass index (BMI), metabolic syndrome (MS) or its individual components (primary hypertension, type 2 diabetes mellitus and dyslipidemias) are risk factors for common urological diseases. Materials and methods Cross-sectional study with data collected on February 28, 2022 from the TriNetX Research Network. Patients were divided in cohorts according to their BMI, presence of MS (BMI > 30 kg/m 2 , type 2 diabetes mellitus, primary hypertension and disorders of lipoprotein metabolism) and its individual components and its association with common urological conditions was determined. For each analysis, odds ratio (OR) with 95% confidence intervals were calculated. Statistical significance was assessed at p < .05. Results BMI > 30 kg/m 2 was associated with increased risk of lithiasis, kidney cancer, overactive bladder, male hypogonadism, benign prostatic hyperplasia, and erectile dysfunction ( p < .05). On the contrary, BMI was inversely associated with ureteral, bladder and prostate cancer ( p < .05). In all urological diseases, MS was the strongest risk factor, with prostate cancer (OR = 2.53) showing the weakest and male hypogonadism the strongest (OR = 13.00) associations. Conclusions MS and its individual components were significant risk factors for common urological conditions. Hence holistic approaches with lifestyle modification might prevent common urological disease. Key messages Overall, metabolic syndrome is the strongest risk factor for all the analysed urological diseases. Abnormally high body mass index can be a risk or protective factor depending on the threshold and urological disease that are being evaluated. Metabolic syndrome and increased BMI should be considered important factors associated to the prevalence of common urological diseases.

Incidental prostate cancer after holmium laser enucleation of the prostate: Critical analysis of independent risk factors and impact on surgical outcomes

“…Other authors have also reported a similar association between prostate cancer and hypertension, although the precise cause‐and‐effect relationship of these findings remains unclear. 20 A prior study conducted by Ohwaki et al reported a link between diabetes and the diagnosis of high‐risk iPCa. 7 However, we did not notice any such association in our study.…”

Lipid Profiles Impact on the Oncologic Outcome of Upper Tract Urothelial Carcinoma

“…There is evidence to suggest that elevated levels of serum LDL are causally linked to an increased risk of renal cancer, independent of TG and HDL levels [ 18 ]. Recent findings showed a significant positive association between dyslipidemia (elevated TG and decreased HDL) and ureteral cancer (odds ratio (OR) = 1.69; confidence interval (CI) = 1.51 - 1.90; P < 0.05) as well as bladder cancer (OR = 1.55; CI = 1.50 - 1.60; P < 0.05) [ 19 ]. The other comprehensive study called the Metabolic Syndrome and Cancer Project (Me-Can) 2.0 discovered a clear positive correlation between high CHOL levels and the risk of non-muscle invasive bladder cancer among men [ 20 ].…”

Epidemiology, Risk Factors, and Clinical Outcomes of AKI in Pediatric Hematopoietic Stem Cell Transplant Patients

“…The TriNetX platform has been used extensively in both adult and pediatric patient populations to report epidemiological outcomes and risk assessments in an array of pathologic settings. 13 – 15 This study followed the Strengthening the Reporting of Observational Studies in Epidemiology reporting guidelines. 16 Description of the database is further laid out in the Supplemental Methods .…”